## Pre-operative Medical Management of Cholesteatoma **Key Point:** Fluoroquinolone otic drops (ofloxacin, ciprofloxacin) are the gold standard for controlling active infection in cholesteatoma before definitive surgical management. ### Why Ofloxacin Otic Drops? 1. **Broad-spectrum coverage** — effective against *Pseudomonas aeruginosa*, *Staphylococcus aureus*, and other gram-negative organisms commonly isolated from cholesteatoma 2. **Biofilm penetration** — achieves high local concentrations and penetrates bacterial biofilms in the middle ear and mastoid 3. **Safe in perforated ears** — unlike aminoglycosides, fluoroquinolones are not ototoxic and are safe with tympanic membrane perforation 4. **Reduces drainage** — helps control suppuration pre-operatively, reducing operative field contamination ### Fluoroquinolone Otic Agents | Agent | Advantages | Disadvantages | |-------|-----------|---------------| | **Ofloxacin** | Broad-spectrum, non-ototoxic, penetrates biofilm | Cost (higher) | | **Ciprofloxacin** | Similar efficacy, widely available | Similar profile | | ~~Gentamicin~~ | Gram-negative coverage | **Ototoxic** — contraindicated in perforated ears | | ~~Aminoglycosides~~ | Potent gram-negative coverage | **Ototoxic** — risk of permanent sensorineural hearing loss | **High-Yield:** Aminoglycosides (gentamicin, tobramycin) are **absolutely contraindicated** in cholesteatoma with tympanic membrane perforation because they cross the round window membrane and cause irreversible ototoxicity. **Clinical Pearl:** The goal of pre-operative medical management is to reduce discharge and infection, making the surgical field cleaner and reducing post-operative infection risk. However, medical therapy alone does NOT cure cholesteatoma — surgery is definitive.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.